Fludarabine, Cyclophosphamide, and Rituximab Versus Pentostatin, Cyclophosphamide, and Rituximab in Previously Untreated or Treated B-Cell Chronic Lymphocytic Leukemia Patients
The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2008 by US Oncology Research.
Recruitment status was Active, not recruiting
Recruitment status was Active, not recruiting
Sponsor:
US Oncology Research
Collaborator:
Astex Pharmaceuticals
Information provided by:
US Oncology Research
ClinicalTrials.gov Identifier:
NCT00254163
First received: November 9, 2005
Last updated: February 27, 2008
Last verified: February 2008
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Estimated Primary Completion Date: | No date given |